HOME
>
臨床医学：一般
>
集中治療
> 教えて!　ICU　Part 3　集中治療に強くなる

教えて!　ICU　Part 3　集中治療に強くなる

出版社：	羊土社
著者：	早川桂(著)
発行日：	2017-10-15
分野：	臨床医学：一般 > 集中治療
ISBN：	9784758118156
電子書籍版：	2017-10-15 （第1刷）

書籍・雑誌

≪全国送料無料でお届け≫

取寄せ目安：8～14営業日

4,290 円(税込)

購入する

電子書籍

章別単位での購入はできません

ブラウザ、アプリ閲覧

4,290 円(税込)

購入する

商品紹介

レジデントノート誌の人気連載の単行本化，待望の３巻目！敗血症の新定義や抗菌薬適正使用など，ICUの現場で注目されているトピックスについて，研修医目線でやさしく噛み砕いて教えます！

目次

教えて!　ICU　Part 3　集中治療に強くなる

―目次―

第1章　教えて！緊急対応
1 . ICUでの急変!?
　2 . アナフィラキシーへの対応
　3 . 敗血症の新定義（Sepsis-3）

第2章　教えて！意識
　1 . ICUとてんかん発作
　2 . ICUでのせん妄　診断と治療

第3章　教えて！呼吸
　1 . VAP（人工呼吸器関連肺炎）とVAE
　2 . 筋弛緩薬の使い方
　3 . 胸水抜く？or抜かない？

第4章　教えて！循環
　1 . 温故知新スワンガンツカテーテルって何？
　2 . 心不全の病態の基本と治療

第5章　教えて！血栓
　1 . 肺塞栓症（PE）の治療
　2 . 深部静脈血栓症（DVT）の予防
　3 . ICUで出会う血栓性疾患

第6章　教えて！感染
　1 . ICUでの抗真菌薬の使い方
　2 . 抗菌薬の適正使用とPK/PD
　3 . 乳酸値いろいろ

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章教えて ! 緊急対応

P.23 掲載の参考文献

1) Schein RM, et al:Clinical antecedents to in-hospital cardiopulmonary arrest. Chest, 98:1388-1392, 1990(PMID2245680)

2) Franklin C & Mathew J:Developing strategies to prevent inhospital cardiac arrest:analyzing responses of physicians and nurses in the hours before the event. Crit Care Med, 22:244-247, 1994(PMID8306682)

3) 「FCCSプロバイダーマニュアル第2版」(FCCS運営委員会/監), メディカルサイエンスインターナショナル, 2013

4) Kim MM, et al:The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med, 170:369-376, 2010(PMID20177041)

5) Buist MD, et al:Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital:preliminary study. BMJ, 324:387-390, 2002(PMID11850367)

6) 「RRS院内救急対応システム」(児玉貴光, 藤谷茂樹/監), メディカルサイエンスインターナショナル, 2012

P.35 掲載の参考文献

1) Katayama H, et al:Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology, 175:621-628, 1990(PMID2343107)

2) Pumphrey RS:Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy, 30:1144-1150, 2000(PMID10931122)

3) Carson JL, et al:Red blood cell transfusion:a clinical practice guidelinefrom the AABB*. Ann Intern Med, 157:49-58, 2012(PMID22751760)

4) Lieberman P, et al:The diagnosis and management of anaphylaxis practice parameter:2010 update. J Allergy Clin Immunol, 126:477-480, 2010(PMID20692689)

5) Simons FE, et al:2012 Update:World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol, 12:389-399, 2012(PMID22744267)

6) 「アナフィラキシーガイドライン」(一般社団法人日本アレルギー学会/監, Anaphylaxis対策特別委員会/編), 一般社団法人日本アレルギー学会, 2014

7) Sampson HA, et al:Second symposium on the definition and management of anaphylaxis:summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol, 117:391-397, 2006(PMID16461139)

8) Choo KJ, et al:Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev, 4:CD007596, 2012(PMID22513951)

9) Sheikh A, et al:H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev, CD006160, 2007(PMID17253584)

P.48 掲載の参考文献

1) Singer M, et al:The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315:801-810, 2016(PMID26903338)

2) Bone RC, et al:Sepsis syndrome:a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med, 17:389-393, 1989(PMID2651003)

3) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 20:864-874, 1992(PMID1597042)

4) 丸藤哲:総説 SIRS(systemic inflammatory response sydrome)/Sepsisの定義, 病態, 診断, 治療. 日本家畜臨床感染症研究会誌, 6巻3号:67-75, 2011

5) Levy MM, et al:2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med, 31:1250-1256, 2003(PMID12682500)

6) Weiss M, et al:Different patient case mix by applying the 2003 SCCM/ESICM/ACCP/ATS/SIS sepsis definitions instead of the 1992 ACCP/SCCM sepsis definitions in surgical patients:a retrospective observational study. BMC Med Inform Decis Mak, 9:25. doi:10.1186/1472-6947-9-25, 2009(PMID19450242)

7) Zhao H, et al:An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/Surgical Infection Society sepsis definition. Crit Care Med, 40:1700-1706, 2012(PMID19450242)

8) Kaukonen KM, et al:Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med, 372:1629-1638, 2015(PMID25776936)

9) Seymour CW, et al:Assessment of Clinical Criteria for Sepsis:For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315:762-774, 2016(PMID26903335)

10) Shankar-Hari M, et al:Developing a New Definition and Assessing New Clinical Criteria for Septic Shock:For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315:775-787, 2016(PMID26903336)

11) Gerdin M & Baker T:Clinical Criteria to Identify Patients With Sepsis. JAMA, 316:453-4. doi:10.1001/jama.2016.6410.(PMID27458953)

12) Seymour CW & Angus DC:Clinical Criteria to Identify Patients With Sepsis--Reply. JAMA, 316:454. doi:10.1001/jama.2016.6413.(PMID27458955)

第2章教えて ! 意識

P.63 掲載の参考文献

1) Alldredge BK, et al:A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med, 345:631-637, 2001(PMID 11547716)

2) Brophy GM, et al:Guidelines for the evaluation and management of status epilepticus. Neurocrit Care, 17:3-23, 2012(PMID 22528274)

3) Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA, 270:854-859, 1993(PMID 8340986)

4) Betjemann JP & Lowenstein DH:Status epilepticus in adults. Lancet Neurol, 14:615-624, 2015(PMID25908090)

5) Silbergleit R, et al:Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med, 366:591-600, 2012(PMID22335736)

6) 「重症頭部外傷治療・管理のガイドライン第3版」(日本脳神経外科学会, 日本脳神経外傷学会/監, 重症頭部外傷治療・管理のガイドライン作成委員会/編), 医学書院, 2013

7) 「てんかん治療ガイドライン2010」(日本神経学会/監, 「てんかん治療ガイドライン」作成委員会/編), 医学書院, 2010

8) Engel J Jr, et al:A proposed diagnostic scheme for people with epileptic seizures and with epilepsy:report of the ILAE Task Force on Classification and Terminology. Epilepsia, 42:796-803, 2001(PMID 11422340)

9) Blume WT, et al:Glossary of descriptive terminology for ictal semiology:report of the ILAE task force on classification and terminology. Epilepsia, 42:1212-1218, 2001(PMID 11580774)

10) 「教えて!ICU 集中治療に強くなる」(早川桂, 清水敬樹/著), pp23-34, 羊土社, 2013

11) Seder DB, et al:Neurologic outcomes and postresuscitation care of patients with myoclonus following cardiac arrest. Crit Care Med, 43:965-972, 2015(PMID 25654176)

12) Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. Brain Resuscitation Clinical Trial I Study Group. N Engl J Med, 314:397-403, 1986(PMID 2868412)

13) Atmaca MM, et al:Intravenous levetiracetam treatment in status epilepticus:A prospective study. Epilepsy Res, 114:13-22, 2015(PMID26088881)

14) Chakravarthi S, et al:Levetiracetam versus phenytoin in management of status epilepticus. J Clin Neurosci, 22:959-963, 2015(PMID25899652)

15) Towne AR, et al:Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology, 54:340-345, 2000(PMID10668693)

16) Claassen J, et al:Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology, 62:1743-1748, 2004(PMID15159471)

17) Dericioglu N, et al:Non-expert use of quantitative EEG displays for seizure identification in the adult neuro-intensive care unit. Epilepsy Res, 109:48-56, 2015(PMID25524842)

P.79 掲載の参考文献

1) Barr J, et al:Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med, 41:263-306, 2013(PMID23269131)

2) 日本集中治療医学会J-PADガイドライン作成委員会:日本版・集中治療室における成人重症患者に対する痛み・不穏・せん妄管理のための臨床ガイドライン. 日本集中治療医学会雑誌, 21:539-579, 2014

3) Pisani MA, et al:Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med, 180:1092-1097, 2009(PMID19745202)

4) 「教えて!ICU 集中治療に強くなる」(早川桂, 清水敬樹/著), pp10-22, 羊土社, 2013

5) 「DSM-IV-TR 精神疾患の診断・統計マニュアル」(American Psychiatric Association/著, 高橋三郎, 他/訳), 医学書院, 2004

6) 「カプラン臨床精神医学ハンドブック第3版」(融道男, 岩脇淳/監訳), メディカル・サイエンス・インターナショナル, 2007

7) 卯野木健:簡便にせん妄を評価できるツールは? EBNursing, 10:627-630, 2010

8) Neto AS, et al:Delirium screening in critically ill patients:a systematic review and meta-analysis. Crit Care Med, 40:1946-1951, 2012(PMID22610196)

9) Mehta S, et al:Prevalence, risk factors, and outcomes of delirium in mechanically ventilated adults. Crit Care Med, 43:557-566, 2015(PMID25493968)

10) Van Rompaey B, et al:Risk factors for delirium in intensive care patients:a prospective cohort study. Crit Care, 13:R77, 2009(PMID19457226)

11) Barr J, et al:Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med, 41:263-306, 2013(PMID23269131)

12) Riker RR, et al:Dexmedetomidine vs midazolam for sedation of critically ill patients:a randomized trial. JAMA, 301:489-499, 2009(PMID19188334)

13) Jakob SM, et al:Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation:two randomized controlled trials. JAMA, 307:1151-1160, 2012(PMID22436955)

14) Riker RR, et al:Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med, 22:433-440, 1994(PMID8124994)

15) Prakanrattana U & Prapaitrakool S:Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care, 35:714-719, 2007(PMID17933157)

第3章教えて ! 呼吸

P.91 掲載の参考文献

1) Fagon JY, et al:Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis, 138:110-116, 1988(PMID3144202)

2) Timsit JF, et al:Reappraisal of distal diagnostic testing in the diagnosis of ICU-acquired pneumonia. Chest, 108:1632-1639, 1995(PMID7497774)

3) Fabregas N, et al:Clinical diagnosis of ventilator associated pneumonia revisited:comparative validation using immediate post-mortem lung biopsies. Thorax, 54:867-873, 1999(PMID10491448)

4) Pugin J, et al:Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis, 143:1121-1129, 1991(PMID2024824)

5) Fartoukh M, et al:Diagnosing pneumonia during mechanical ventilation:the clinical pulmonary infection score revisited. Am J Respir Crit Care Med, 168:173-179, 2003(PMID12738607)

6) Ramirez P, et al:Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J, 31:356-362, 2008(PMID17959634)

7) Miller DL:A Study of Techniques for the Examination of Sputum in a Field Survey of Chronic Bronchitis. Am Rev Respir Dis, 88:473-483, 1963(PMID14068432)

8) Centers for Disease Control and Prevention. National Healthcare Safety Network(NHSN). Surveillance for Ventilator-associated Events:http://www.cdc.gov/nhsn/acute-care-hospital/vae/

9) American Thoracic Society;Infectious Diseases Society of America:Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 171:388-416, 2005(PMID15699079)

10) Cook D & Mandell L:Endotracheal aspiration in the diagnosis of ventilatorassociated pneumonia. Chest, 117:195S-197S, 2000(PMID10816036)

11) Berton DC, et al:Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. CD006482

12) Klein Klouwenberg PM, et al:Electronic implementation of a novel surveillance paradigm for ventilator-associated events. Feasibility and validation. Am J Respir Crit Care Med, 189:947-955, 2014(PMID24498886)

13) The Society for Healthcare Epidemiology of America(SHEA):http://www.shea-online.org

14) 日本集中治療医学会ICU機能評価委員会:人工呼吸関連肺炎予防バンドル2010改訂版. 2010 http://www.jsicm.org/pdf/2010VAP.pdf

15) Morris AC, et al:Reducing ventilator-associated pneumonia in intensive care:impact of implementing a care bundle. Crit Care Med, 39:2218-2224, 2011(PMID21666444)

16) 「教えて!ICU Part2 集中治療に強くなる」(早川桂/著), pp54-68, 羊土社, 2015

P.105 掲載の参考文献

1) Minton MD, et al:Increases in intracranial pressure from succinylcholine:prevention by prior nondepolarizing blockade. Anesthesiology, 65:165-169, 1986(PMID2874752

2) Heier T, et al:Hemoglobin desaturation after succinylcholine-induced apnea:a study of the recovery of spontaneous ventilation in healthy volunteers. Anesthesiology, 94:754-759, 2001(PMID11388524)

3) 「Miller's Anesthesia 6th Edition」(Ronald D Miller, ed), Churchill Livingstone, 2004

4) 「Morgan and Mikhail's Clinical Anesthesiology, 5th edition」(John Butterworth, et al, eds), McGraw-Hill Education, 2013

5) ブリディオン(R), MSD株式会社:https://www.msdconnect.jp/products/bridion/index.xhtml

6) Cammu G, et al:Repeat dosing of rocuronium 1.2mg kg-1 after reversal of neuromuscular block by sugammadex 4.0mg kg-1 in anaesthetized healthy volunteers:a modelling-based pilot study. Br J Anaesth, 105:487-492, 2010(PMID20630888)

7) Abouassaly CT, et al:Postoperative neuromuscular blocker use is associated with higher primary fascial closure rates after damage control laparotomy. J Trauma, 69:557-561, 2010(PMID20838126)

8) Lascarrou JB, et al:Neuromuscular blockade during therapeutic hypothermia after cardiac arrest:observational study of neurological and infectious outcomes. Resuscitation, 85:1257-1262, 2014(PMID24892266)

9) Papazian L, et al:Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med, 363:1107-1116, 2010(PMID20843245)

10) 「ARDS 診療ガイドライン2016 Part2」(3学会合同ARDS診療ガイドライン2016作成委員会/編), pp101-108, 総合医学社, 2016

11) Alhazzani W, et al:Neuromuscular blocking agents in acute respiratory distress syndrome:a systematic review and meta-analysis of randomized controlled trials. Crit Care, 17:R43. doi:10.1186/cc12557, 2013(PMID23497608)

12) Bolton CF, et al:Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry, 47:1223-1231, 1984(PMID6094735)

13) De Jonghe B, et al:Paresis acquired in the intensive care unit:a prospective multicenter study. JAMA, 288:2859-2867, 2002(PMID12472328)

P.116 掲載の参考文献

1) Light RW, et al:Pleural effusions:the diagnostic separation of transudates and exudates. Ann Intern Med, 77:507-513, 1972(PMID4642731)

2) Light RW:Clinical practice. Pleural effusion. N Engl J Med, 346:1971-1977, 2002(PMID12075059)

3) Heffner JE, et al:Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest, 111:970-980, 1997(PMID9106577)

4) Gordon CE, et al:Pneumothorax following thoracentesis:a systematic review and meta-analysis. Arch Intern Med, 170 :332-339, 2010(PMID20177035)

5) Trapnell DH & Thurston JG:Unilateral pulmonary oedema after pleural aspiration. Lancet, 1:1367-1369, 1970(PMID4194125)

6) Jones PW, et al:Ultrasound-guided thoracentesis:is it a safer method? Chest, 123:418-423, 2003(PMID12576360)

7) Feller-Kopman D, et al:Large-volume thoracentesis and the risk of reexpansion pulmonary edema. Ann Thorac Surg, 84 :1656-1661, 2007(PMID17954079)

8) 早川桂:「教えて!ICU Part2 集中治療に強くなる」, pp203-213, 羊土社, 2015

9) Younes RN, et al:When to remove a chest tube? A randomized study with subsequent prospective consecutive validation. J Am Coll Surg, 195:658-662, 2002(PMID12437253)

第4章教えて ! 循環

P.130 掲載の参考文献

1) 「ミラー麻酔科学」(Miller RD/著, 武田純三/監), pp813-815, メディカル・サイエンス・インターナショナル, 2007

2) Newell KA, et al:Pheochromocytoma multisystem crisis. A surgical emergency. Arch Surg, 123:956-959, 1988(PMID2899426)

3) 「Marino's ICU Book, 4th ed.」(Marino PL, ed.), Lippincott Williams & Wilkins, 2014

4) Forrester JS, et al:Medical therapy of acute myocardial infarction by application of hemodynamic subsets(first of two parts). N Engl J Med, 295:1356-1362, 1976(PMID790191)

5) Edwards Critical Care Education:血行動態モニタリング-その生理学的基礎と臨床応用-. http://edwards.jp/jp/wp-content/uploads/2014/10/ecce_hm.pdf

6) 早川桂, 清水敬樹:ScvO2 からみる循環管理.「教えて!ICU 集中治療に強くなる」, pp85-98, 羊土社, 2013

7) Connors AF Jr, et al:The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA, 276:889-897, 1996(PMID8782638)

8) Sandham JD, et al:A randomized, controlled trial of the use of pulmonaryartery catheters in high-risk surgical patients. N Engl J Med, 348:5-14, 2003(PMID12510037)

9) Richard C, et al:Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome:a randomized controlled trial. JAMA, 290:2713-2720, 2003(PMID14645314)

10) Binanay C, et al:Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness:the ESCAPE trial. JAMA, 294:1625-1633, 2005(PMID16204662)

11) American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization:Practice guidelines for pulmonary artery catheterization:an updated report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Anesthesiology, 99:988-1014, 2003(PMID14508336)

12) Kumar A, et al:Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med, 32:691-699, 2004(PMID15090949)

P.148 掲載の参考文献

1) Maisel A:B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient. Rev Cardiovasc Med, 3 Suppl 4:S10-7, 2002(PMID12439426)

2) Maisel A, et al:Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol, 44:1328-1333, 2004(PMID15364340)

3) Caldentey G, et al:Prognostic value of the physical examination in patients with heart failure and atrial fibrillation:insights from the AF-CHF trial (atrial fibrillation and chronic heart failure). JACC Heart Fail, 2:15-23, 2014(PMID24622114)

4) McKee PA, et al:The natural history of congestive heart failure:the Framingham study. N Engl J Med, 285:1441-1446, 1971(PMID5122894)

5) Wang CS, et al:Does this dyspneic patient in the emergency department have congestive heart failure? JAMA, 294:1944-1956, 2005(PMID16234501)

6) 「教えて!ICU 集中治療に強くなる」(早川桂, 清水敬樹/著), pp.72-84, 羊土社, 2013

7) Mebazaa A, et al:Practical recommendations for prehospital and early inhospital management of patients presenting with acute heart failure syndromes. Crit Care Med, 36(1 Suppl):S129-S139, 2008(PMID18158472)

8) Felker GM, et al:Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med, 364:797-805, 2011(PMID21366472)

9) Cotter G, et al:Randomised trial of high-dose isosorbide dinitrate plus lowdose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet, 351:389-393, 1998(PMID9482291)

第5章教えて ! 血栓

P.162 掲載の参考文献

1) Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors(THRIFT)Consensus Group. BMJ, 305:567-574, 1992(PMID1298229)

2) Sandler DA & Martin JF:Autopsy proven pulmonary embolism in hospital patients:are we detecting enough deep vein thrombosis? J R Soc Med, 82:203-205, 1989(PMID2716016)

3) Konstantinides SV, et al:2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 35:3033-3069, 2014(PMID25173341)

4) Jaff MR, et al:Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension:a scientific statement from the American Heart Association. Circulation, 123:1788-1830, 2011(PMID21422387)

5) 日本循環器学会:循環器病の診断と治療に関するガイドライン(2008年度合同研究班報告). 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン(2009年改訂版):http://www.j-circ.or.jp/guideline/pdf/JCS2009_andoh_h.pdf

6) McConnell MV, et al:Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol, 78:469-473, 1996(PMID8752195)

7) Wells PS, et al:Derivation of a simple clinical model to categorize patients probability of pulmonary embolism:increasing the models utility with the SimpliRED D-dimer. Thromb Haemost, 83:416-420, 2000(PMID10744147)

8) Aujesky D, et al:Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med, 172 :1041-1046, 2005(PMID16020800)

9) Jimenez D, et al:Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med, 170:1383-1389, 2010(PMID20696966)

10) Righini M, et al:Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism:the ADJUST-PE study. JAMA, 311:1117-1124, 2014(PMID24643601)

11) van Belle A, et al:Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA, 295:172-179, 2006(PMID16403929)

12) Kanter DS, et al:Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest, 111:1241-1245, 1997(PMID9149576)

13) Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J, 21:1301-1336, 2000(PMID10952823)

14) Meyer G, et al:Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med, 370:1402-1411, 2014(PMID24716681)

P.175 掲載の参考文献

1) 「教えて!ICU Part 2 集中治療に強くなる」(早川桂/著), pp174-189, 羊土社, 2015

2) Dennis M, et al:Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke(CLOTS trial 1):a multicentre, randomised controlled trial. Lancet, 373:1958-1965, 2009(PMID19477503)

3) Giddings JC, et al:Systemic haemostasis after intermittent pneumatic compression. Clues for the investigation of DVT prophylaxis and travellers thrombosis. Clin Lab Haematol, 26:269-273, 2004(PMID15279664)

4) Morris RJ, et al:Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis? A systematic review of direct clinical comparisons. Ann Surg, 251:393-396, 2010(PMID20083996)

5) 「循環器病ガイドシリーズ. 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン(2009年改訂版)」http://www.j-circ.or.jp/guideline/pdf/JCS2009_andoh_h.pdf

6) The CLOTS Collaboration:http://www.dcn.ed.ac.uk/clots/

7) CLOTS Trial Collaboration1:Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke:a randomized trial. Ann Intern Med, 153:553-562, 2010(PMID20855784)

8) Dennis M, et al:Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke(CLOTS 3):a multicentre randomised controlled trial. Lancet, 382:516-524, 2013(PMID23727163)

9) Decousus H, et al:A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med, 338:409-415, 1998(PMID9459643)

10) PREPIC Study Group:Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism:the PREPIC(Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circuration, 112:416-422, 2005(PMID16009794)

11) Sarosiek S, et al:Indications, complications, and management of inferior vena cava filters:the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med, 173:513-517, 2013(PMID23552968)

12) Guyatt GH, et al:Executive summary:Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141:7S-47S, 2012(PMID22315257)

P.187 掲載の参考文献

1) Lee DH & Warkentin TE:Frequency of heparin induced thrombocytopenia. 「Heparin-Induced Thrombocytopenia. 3rd ed」(Warkentin TE & Greinacher A, eds), pp107-148, Marcel Dekker, 2004

2) 「教えて!ICU 集中治療に強くなる」(早川桂, 清水敬樹/著), pp99-112, 羊土社, 2013

3) Greinacher A, et al:Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost, 94:132-135, 2005(PMID16113796)

4) Rosenberger LH, et al:Bilateral adrenal hemorrhage:the unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia. Crit Care Med, 39:833-838, 2011(PMID21242799)

5) Greinacher A, et al:Heparin-induced thrombocytopenia with thromboembolic complications:meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood, 96:846-851, 2000(PMID10910895)

6) Sadler JE:Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood, 112:11-18, 2008(PMID18574040)

7) Scully M, et al:Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol, 158:323-335, 2012(PMID22624596)

8) Stawicki SP, et al:Septic embolism in the intensive care unit. Int J Crit Illn Inj Sci, 3:58-63, 2013(PMID23724387)

9) Chirinos JA, et al:The evolution of Lemierre syndrome:report of 2 cases and review of the literature. Medicine, 81:458-465, 2002(PMID12441902)

10) Forrester LJ, et al:Aggregation of platelets by Fusobacterium necrophorum. J Clin Microbiol, 22:245-249, 1985(PMID4031037)

11) Stein PD, et al:Fat embolism syndrome. Am J Med Sci, 336:472-477, 2008(PMID19092320)

12) Gurd AR:Fat embolism:an aid to diagnosis. J Bone Joint Surg Br, 52:732-737, 1970(PMID5487573)

第6章教えて ! 感染

P.201 掲載の参考文献

1) Wisplinghoff H, et al:Nosocomial bloodstream infections in US hospitals:analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis, 39:309-317, 2004(PMID15306996)

2) 国立感染症研究所:真菌症2012年現在. IASR, 34:1-2, 2013

3) 「深在性真菌症の診断・治療ガイドライン2014」(深在性真菌症のガイドライン作成委員会/編), 協和企画, 2014 http://www.mycoses.jp/guideline/

4) Pfaller MA, et al:Result from the ARTEMIS DISK grobal antifungal surveillance study 1997 to 2007:a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol, 48:1366-1377, 2010(PMID20164282)

5) Pfaller MA, et al:Candida bloodstream infections:comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. Antimicrob Agents Chemother, 55:561-566, 2011(PMID21115790)

6) Mora-Duarte J, et al:Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med, 347:2020-2029, 2002(PMID12490683)

7) T akesue Y, et al:Management bundles for candidaemia:the impact of compliance on clinical outcomes. J Antimicrob Chemother, 70:587-593, 2015(PMID25326087)

8) 真菌症フォーラム ACTIONs Project, ACTIONs Bundle 2014, カンジダ感染症チェックリスト http://mycoses.jp/actions_project/index.html

P.212 掲載の参考文献

1) 「教えて!ICU 集中治療に強くなる」(早川桂, 清水敬樹/著), pp126-139, 羊土社, 2013

2) Carmeli Y, et al:Emergence of antibiotic-resistant Pseudomonas aeruginosa:comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother, 43:1379-1382, 1999(PMID10348756)

3) Lodise TP, et al:Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis, 49:507-514, 2009(PMID19586413)

4) Beibei L, et al:Linezolid versus vancomycin for the treatment of gram-positive bacterial infections:meta-analysis of randomised controlled trials. Int J Antimicrob Agents, 35:3-12, 2010(PMID19900794)

5) American Thoracic Society & Infectious Diseases Society of America:Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 171:388-416, 2005(PMID15699079)

6) Steinkraus G, et al:Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillinresistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother, 60:788-794, 2007(PMID17623693)

P.222 掲載の参考文献

1) Boekstegers P, et al:Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med, 22:640-650, 1994(PMID8143474)

2) Garcia-Alvarez M, et al:Sepsis-associated hyperlactatemia. Crit Care, 18:503, 2014(PMID25394679)

3) Suetrong B & Walley KR:Lactic acidosis in sepsis:It's not all anaerobic:Implications for diagnosis and management. Chest, 149:252-261, 2016(PMID26378980)

4) Alamdari N, et al:Temporal changes in the involvement of pyruvate dehydrogenase complex in muscle lactate accumulation during lipopolysaccharide infusion in rats. J Physiol, 586:1767-1775, 2008(PMID18218678)

5) Singer M, et al:The third international consensus definitions for sepsis and septic shock(Sepsis-3). JAMA, 315:801-810, 2016(PMID26903338)

6) Wacharasint P, et al:Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock, 38:4-10, 2012(PMID22552014)

7) Jansen TC, et al:Early lactate-guided therapy in intensive care unit patients:a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med, 182:752-761, 2010(PMID20463176)

8) Leverve XM:Energy metabolism in critically ill patients:lactate is a major oxidizable substrate. Curr Opin Clin Nutr Metab Care, 2:165-169, 1999(PMID10453349)

9) Brooks GA:Lactate shuttles in nature. Biochem Soc Trans, 30:258-264, 2002(PMID12023861)

10) Bakker J, et al:Clinical use of lactate monitoring in critically ill patients. Ann Intensive Care, 3:12, 2013(PMID23663301)

11) PRISM Investigators, et al:Early, Goal-Directed Therapy for Septic Shock-A Patient-Level Meta-Analysis. N Engl J Med, 376:2223-2234, 2017(PMID28320242)

書評

書評を投稿する

最近チェックした商品履歴

Loading...